Development of therapeutic antibodies for the treatment of diseases

Volume: 27, Issue: 1, Pages: 1 - 30
Published: Jan 2, 2020
Abstract
It has been more than three decades since the first monoclonal antibody was approved by the United States Food and Drug Administration (US FDA) in 1986, and during this time, antibody engineering has dramatically evolved. Current antibody drugs have increasingly fewer adverse effects due to their high specificity. As a result, therapeutic antibodies have become the predominant class of new drugs developed in recent years. Over the past five...
Paper Details
Title
Development of therapeutic antibodies for the treatment of diseases
Published Date
Jan 2, 2020
Volume
27
Issue
1
Pages
1 - 30
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.